Estimating the long term cost savings from the treatment of Alzheimer's disease: A modelling approach

被引：2
|
作者：
Neumann, PJ [1 ]
机构：
[1] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
来源：
PHARMACOECONOMICS | 2000年 / 17卷 / 01期
关键词：
Public Health; Adverse Effect; Health Outcome; Nursing Home; Drug Therapy;
D O I：
10.2165/00019053-200017010-00007
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：109 / 109
页数：1
相关论文
共 50 条
  • [41] Is Long-Term Treatment of Alzheimer’s Disease with Cholinesterase Inhibitor Therapy Justified?
    Ben Seltzer
    Drugs & Aging, 2007, 24 : 881 - 890
  • [42] Immunological approach for the treatment of Alzheimer's disease
    Solomon, B
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2003, 20 (03) : 283 - 286
  • [43] Immunological approach for the treatment of Alzheimer’s disease
    Beka Solomon
    Journal of Molecular Neuroscience, 2003, 20 : 283 - 286
  • [44] The treatment of Alzheimer's disease: The approach from a clinical specialist in the trenches
    Hake, AM
    SEMINARS IN NEUROLOGY, 2002, 22 (01) : 71 - 74
  • [45] Long-term treatment with galantamine (Reminyl®) slows the disease progression of patients with Alzheimer's disease
    Hager, K
    Schwalen, S
    Schreiner, A
    Schmitt, A
    PROCEEDINGS OF THE 14TH ALZHEIMER EUROPEAN CONFERENCE, 2004, : 39 - 44
  • [46] The needs of the caregiver in the long-term treatment of Alzheimer disease
    Bullock, R
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2004, 18 : S17 - S23
  • [47] Long-term treatment for patients with Alzheimer disease - Introduction
    Cummings, JL
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2004, 18 : S1 - S1
  • [48] Estimating the long-term effect of early levodopa treatment initiation in Parkinson's disease
    van der Heuvel, L.
    Krijthe, J.
    Evers, L.
    Meinders, M.
    Post, B.
    Heskes, T.
    Bloem, B.
    MOVEMENT DISORDERS, 2019, 34
  • [49] Potential Savings in the Cost of Caring for Alzheimer’s DiseaseTreatment with Rivastigmine
    A. Brett Hauber
    Josephine A. Mauskopf
    Edward H. Snyder
    PharmacoEconomics, 2000, 18 (6) : 609 - 612
  • [50] LONG-TERM RESPONSE TO CHOLINESTERASE INHIBITOR TREATMENT IN ALZHEIMER'S DISEASE: AN fMRI STUDY
    Miettinen, P. S.
    Jauhiainen, A. M.
    Tarkka, I. M.
    Pihlajamaki, M.
    Grohn, H.
    Niskanen, E.
    Hanninen, T.
    Vanninen, R.
    Soininen, H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 62 - 62
12345